Swiss, German drugmakers join U.S. price freeze
U.S. Secretary of State Mike Pompeo and President Donald Trump listen during a cabinet meeting at the White House in Washington, U.S., July 18, 2018. REUTERS/Leah Millis/ ZURICH (Reuters) - European drugmakers Roche, Bayer and Merck KGaA became the latest companies to freeze prices in the United States following criticism by the Trump administration of the cost of medicine. Roche, Bayer and Merck KGaA all said on Friday they would not seek to lift prices this year in the world's biggest drug market, following Novartis, Pfizer and U.S. ...
Click
To Read Full Article